JP2018508528A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018508528A5 JP2018508528A5 JP2017546208A JP2017546208A JP2018508528A5 JP 2018508528 A5 JP2018508528 A5 JP 2018508528A5 JP 2017546208 A JP2017546208 A JP 2017546208A JP 2017546208 A JP2017546208 A JP 2017546208A JP 2018508528 A5 JP2018508528 A5 JP 2018508528A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- vegf
- diabetic
- fragment
- isolated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562126968P | 2015-03-02 | 2015-03-02 | |
| US62/126,968 | 2015-03-02 | ||
| PCT/US2016/020443 WO2016141053A1 (en) | 2015-03-02 | 2016-03-02 | Peptides for inhibiting angiogenesis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018508528A JP2018508528A (ja) | 2018-03-29 |
| JP2018508528A5 true JP2018508528A5 (https=) | 2019-04-11 |
| JP6896641B2 JP6896641B2 (ja) | 2021-06-30 |
Family
ID=55543089
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017546208A Active JP6896641B2 (ja) | 2015-03-02 | 2016-03-02 | 血管新生阻害ペプチド |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US9675660B2 (https=) |
| EP (1) | EP3265110B1 (https=) |
| JP (1) | JP6896641B2 (https=) |
| KR (1) | KR20170122762A (https=) |
| CN (1) | CN107427549B (https=) |
| AU (1) | AU2016226264B2 (https=) |
| BR (1) | BR112017018665A2 (https=) |
| CA (1) | CA2977389A1 (https=) |
| DK (1) | DK3265110T3 (https=) |
| ES (1) | ES2820710T3 (https=) |
| IL (1) | IL253966B (https=) |
| MX (1) | MX2017011170A (https=) |
| PH (1) | PH12017501549B1 (https=) |
| PL (1) | PL3265110T3 (https=) |
| RU (1) | RU2708375C2 (https=) |
| SG (1) | SG11201706799YA (https=) |
| WO (1) | WO2016141053A1 (https=) |
| ZA (1) | ZA201705934B (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2022500463A (ja) * | 2018-09-11 | 2022-01-04 | アンビション ソチエタ レスポンサビリタ リミタータ | ペプチドおよびその医学的使用 |
| WO2020053772A1 (en) * | 2018-09-11 | 2020-03-19 | Anbition S.R.L. | Peptides and medical uses thereof |
| CN113755634A (zh) * | 2021-10-12 | 2021-12-07 | 河南省农业科学院烟草研究所 | 一种鸢尾丝囊霉菌分子检测的特异引物及其检测方法 |
| CN115737677B (zh) * | 2022-07-25 | 2024-09-06 | 天津医科大学总医院 | 一种多肽修饰的金纳米颗粒在制备抑制糖尿病视网膜病变药物中的用途 |
| KR102587729B1 (ko) * | 2023-02-27 | 2023-10-12 | 주식회사 아이바이오코리아 | 펩타이드를 포함하는 당뇨망막병증의 치료용 조성물 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4554101A (en) | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
| GB9718609D0 (en) | 1997-09-02 | 1997-11-05 | Imp College Innovations Ltd | Fusion protein |
| EP1684692A2 (en) * | 2003-10-29 | 2006-08-02 | The Johns Hopkins University | Pigment epithelium-derived factor, novel biological activity and methods of use |
| CA2545062A1 (en) | 2003-11-06 | 2005-05-26 | Research Development Foundation | Selective inhibitors of nuclear factor-kb activation and uses thereof |
| JP2008509157A (ja) * | 2004-08-06 | 2008-03-27 | ソフェリオン セラピューティクス，インコーポレイテッド | 抗血管新生ペプチドおよびその使用方法 |
| EP2283028A2 (en) * | 2007-08-08 | 2011-02-16 | The Board of Regents of The University of Texas System | Vegfr-1/nrp-1 targeting peptides |
| JP2011518178A (ja) * | 2008-04-16 | 2011-06-23 | ユニヴァーシティー オブ ユタ リサーチ ファウンデーション | 病的血管形成および脈管透過性の処置用の組成物および方法 |
| FR2940032B1 (fr) | 2008-12-23 | 2013-08-09 | Seb Sa | Panier de cuisson d'aliments et systeme de cuisson correspondant |
| US20100190691A1 (en) | 2009-01-27 | 2010-07-29 | Trojan Technologies, Ltd | Delivery of nucleic acids using cell-penetrating peptides |
| EP2439514A1 (en) | 2010-10-01 | 2012-04-11 | Aqsens Oy | Method, apparatus, and system for examining optically a sample carried in a plurality of wells |
| BR112013032108B1 (pt) * | 2011-06-13 | 2021-10-26 | The Board Of Trustees Of The University Of Illinois | Peptídeos conjugados, usos dos mesmos e de um peptídeo isolado, bem como formulação farmacêutica |
| CN102286101B (zh) * | 2011-08-08 | 2013-05-08 | 常州亚当生物技术有限公司 | 抗VEGF单克隆抗体Fab片段Vasculizumab及其应用 |
-
2016
- 2016-03-02 US US15/058,938 patent/US9675660B2/en active Active
- 2016-03-02 BR BR112017018665-9A patent/BR112017018665A2/pt active Search and Examination
- 2016-03-02 EP EP16710568.3A patent/EP3265110B1/en active Active
- 2016-03-02 JP JP2017546208A patent/JP6896641B2/ja active Active
- 2016-03-02 CA CA2977389A patent/CA2977389A1/en active Pending
- 2016-03-02 CN CN201680012874.6A patent/CN107427549B/zh not_active Expired - Fee Related
- 2016-03-02 DK DK16710568.3T patent/DK3265110T3/da active
- 2016-03-02 AU AU2016226264A patent/AU2016226264B2/en active Active
- 2016-03-02 RU RU2017133101A patent/RU2708375C2/ru active
- 2016-03-02 WO PCT/US2016/020443 patent/WO2016141053A1/en not_active Ceased
- 2016-03-02 KR KR1020177024830A patent/KR20170122762A/ko not_active Ceased
- 2016-03-02 PL PL16710568T patent/PL3265110T3/pl unknown
- 2016-03-02 SG SG11201706799YA patent/SG11201706799YA/en unknown
- 2016-03-02 MX MX2017011170A patent/MX2017011170A/es unknown
- 2016-03-02 ES ES16710568T patent/ES2820710T3/es active Active
-
2017
- 2017-05-22 US US15/602,096 patent/US10064911B2/en active Active
- 2017-08-13 IL IL253966A patent/IL253966B/en active IP Right Grant
- 2017-08-29 PH PH12017501549A patent/PH12017501549B1/en unknown
- 2017-08-31 ZA ZA2017/05934A patent/ZA201705934B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018508528A5 (https=) | ||
| MX2022001433A (es) | Tratamiento personalizado de enfermedades oftalmologicas. | |
| Casini et al. | The β-adrenergic system as a possible new target for pharmacologic treatment of neovascular retinal diseases | |
| MX2013003890A (es) | Composiciones y metodos para tratar edema ocular, neovascularizacion y enfermedades relacionadas. | |
| RU2014129316A (ru) | Способы ингибирования глазного ангиогенеза | |
| EP4477233A3 (en) | A stable liquid formulation of fusion protein with igg fc domain | |
| JP2017515811A5 (https=) | ||
| FI3717636T3 (fi) | Adenoassosioidun viruksen kapsidivariantteja ja käyttö angiogeneesin estämisessä | |
| MX2021006092A (es) | Uso de un antagonista de factor de crecimiento endotelial vascular para tratar trastornos oculares angiogenicos. | |
| JP2017537985A5 (https=) | ||
| JP2019535651A5 (https=) | ||
| Hennig et al. | Nanoparticles for the treatment of ocular neovascularizations | |
| RU2017133101A (ru) | Пептиды для ингибирования ангиогенеза | |
| JP2016521712A5 (https=) | ||
| JP2017532965A5 (https=) | ||
| IL310376B1 (en) | Methods and compositions for treating angiogenic disorders using anti-VEGF factors | |
| WO2014062659A4 (en) | Methods of treating ocular diseases | |
| JP2016508372A5 (https=) | ||
| JP2016536369A5 (https=) | ||
| PH12020551015A1 (en) | Medicine for preventing or treating ophthalmic disease associated with enhanced intraocular neovascularization and/or intraocular vascular permeability | |
| MX2021005077A (es) | Peptidos y composiciones farmaceuticas para tratar enfermedades oculares. | |
| JP2018530574A5 (https=) | ||
| CN111132664A (zh) | 治疗青光眼的Wnt5a的调节 | |
| JP2017524727A5 (https=) | ||
| JP2013513606A5 (https=) |